Realtor diagnosed with colon cancer reveals symptoms she ignored – NBC Chicago

Understanding the Rising Cases of Colorectal Cancer

Colorectal cancer remains a prevalent concern across generations. Despite its common association with older adults, it can affect individuals at any age, as demonstrated by Jenn Henry’s case. In September 2023, Henry, a realtor from Geneva, was diagnosed with stage four colorectal cancer, having ignored several warning signs such as rapid weight loss and digestive issues.

Her experience mirrors a growing trend where individuals delay medical checkups due to busy lifestyles, potentially leading to late diagnoses. The lack of attention towards early symptoms can have severe consequences, underscoring the importance of awareness and timely intervention.

The Role of Lifestyle and Genetics in Colorectal Cancer

Genetics indeed play a pivotal role in the risk of developing colorectal cancer, but lifestyle choices cannot be disregarded. According to Dr. John Abad, a surgical oncologist at Northwestern Medicine, factors such as a sedentary lifestyle, heavy alcohol consumption, and a diet high in red and processed meats significantly increase the risk ([1](https://www.cancer.org/cancer/colorectal-cancer/causes-risks-prevention/prevention.html)).

As preventive measures, adhering to current guidelines—which suggest a first colonoscopy at age 45—is critical. Jenn Henry’s case exemplifies the delayed diagnosis at 54 when she hadn’t undergone this screening ([2](https://www.cdc.gov/cancer/colorectal/pdf/screening-brp-508.pdf)).

Advancements in Treatment: The Power of Immunotherapy

Henry’s journey with immunotherapy highlights a significant advancement in treatment options for colorectal cancer. Immunotherapy, particularly for patients with mismatch repair deficiencies like MSI-high, has shown exceptional results ([3](https://www.clinicalkey.com/#/articles/gastroenterology-and-hepatology/journalarticle/3e317a6c76aaa1836311dd4312e3eb61)). This treatment allows the immune system to effectively target and destroy cancer cells, with reduced toxicity compared to traditional chemotherapy.

About 6% of metastatic colon cancer patients share Henry’s MSI-high profile, and they respond remarkably well to immunotherapy. This breakthrough offers new hope and an avenue toward extended remission for those battling advanced colorectal cancer.

Key Takeaways on Early Detection and Prevention

Henry’s story serves as a powerful reminder of the importance of listening to our bodies and utilizing available medical resources. Colonoscopies are a vital safeguard against colorectal cancer, offering an easy preventative measure that far outweighs the brief inconvenience of the preparation process.

Her message—”Don’t be afraid of the prep work”—is a nurturing nudge toward proactive health management. As she continues her cancer-free life since 2024, Henry’s narrative encourages others to prioritize regular screenings.

FAQs About Colorectal Cancer

• What are the common symptoms of colorectal cancer? Rapid weight loss, crampy abdominal pain, bloody stool, and unexplained anemia.
• At what age should one start getting colonoscopies? Current guidelines recommend starting at the age of 45 ([2](https://www.cdc.gov/cancer/colorectal/pdf/screening-brp-508.pdf)).
• How does immunotherapy work in treating colorectal cancer? It utilizes the body’s immune system to target and destroy cancer cells, with MSI-high patients often responding exceptionally well ([3](https://www.clinicalkey.com/).

Pro Tip

Regularly schedule health check-ups and don’t dismiss persistent symptoms. Early detection is the best defense against many serious health conditions, including colorectal cancer.

Call-to-Action

Have you or a loved one experienced a colorectal cancer journey? Share your story in the comments below and help raise awareness. If you found this article insightful, explore more health-related content, and consider subscribing to our newsletter for the latest information and updates.